Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Computational anatomical methods as applied to ageing and dementia Thompson PM; Apostolova LGBr J Radiol 2007[Dec]; 80 Spec No 2 (ä): S78-91The cellular hallmarks of Alzheimer's disease (AD) accumulate in the living brain up to 30 years before the characteristic symptoms of dementia can be identified. Brain changes in AD are difficult to distinguish from those in normal ageing, and this has led to the development of powerful computational methods to extract statistical information on the brain changes that are characteristic of AD, mild cognitive impairment (MCI) and different dementia subtypes. Time-lapse maps can be built to show how the disease spreads in the brain, and where treatment affects the disease trajectory. Here, we review three computational approaches to map brain deficits in AD: cortical thickness maps, tensor-based morphometry and hippocampal/ventricular surface modelling. Anatomical structures, modelled as three-dimensional geometrical surfaces, are mathematically combined across subjects for group or interval comparisons. Mathematical concepts from computational surface modelling, fluid mechanics and multivariate statistics are exploited to distinguish disease from normal variations in brain structure. These methods yield insight into the dynamics of AD and MCI, showing where brain changes correlate with cognitive or behavioural changes such as language dysfunction or apathy. We describe cortical and hippocampal changes that distinguish dementia subtypes (such as Lewy-body dementia, HIV-associated dementia and AD), and we describe brain changes that predict recovery or decline in those at risk. Finally, we indicate which computational methods are powerful enough to track dementia in clinical trials, on the basis of their efficiency and sensitivity to early change, and the detail in the measures they provide.|Aged[MESH]|Aging/*pathology[MESH]|Alzheimer Disease/pathology[MESH]|Brain Mapping/methods[MESH]|Brain/*pathology[MESH]|Cerebral Cortex/pathology[MESH]|Cerebral Ventricles/pathology[MESH]|Dementia/*pathology[MESH]|Disease Progression[MESH]|Hippocampus/pathology[MESH]|Humans[MESH] |
